Of the 76 CSF samples from symptomatic C9orf72 mutation carriers in all cohorts, 54 (71.1%) were from ALS, 13 (17.1%) from ALS–FTD and nine (11.8%) from FTD. This evidence concerns the gene C9orf72 and frontotemporal dementia.